Emerald Health Sciences Inc.

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Stephen Hall, CFO of Emerald Health Sciences Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emerald Health Sciences Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. 10%+ Owner Common Stock 169,407,901 $3,167,928 $0.0187 22 Feb 2023 Direct
Skye Bioscience, Inc. 10%+ Owner Warrants 0 22 Feb 2023 Direct
Skye Bioscience, Inc. 10%+ Owner Warrants with Credit Facility of Oct 5, 2018 0 22 Feb 2023 Direct
Skye Bioscience, Inc. 10%+ Owner Warrants with Credit Facility of Oct 5, 2018 - T2 0 22 Feb 2023 Direct
Skye Bioscience, Inc. 10%+ Owner Warrants with Credit Facility of Oct 5, 2018 - T3 0 22 Feb 2023 Direct

Insider Reports Filed by Emerald Health Sciences Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 10 Nov 2022 7 +$1,880,141 4 10%+ Owner 17 Mar 2023, 14:52
SKYE Skye Bioscience, Inc. 31 Dec 2021 6 -$256,667 5 10%+ Owner 31 Jan 2022, 12:58